Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concomitant tricuspid valve repair in left ventricular assist device implantation may increase the risk for temporary right ventricular support but does not impact overall outcomes.
Mihalj M, Jezovnik MK, Benk J, Heg D, Podstatzky-Lichtenstein T, Beyersdorf F, Radovancevic R, Gregoric ID, Hunziker L, Siepe M, Reineke D. Mihalj M, et al. Among authors: heg d. Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac555. doi: 10.1093/ejcts/ezac555. Eur J Cardiothorac Surg. 2022. PMID: 36469336
External validity of the "all-comers" design: insights from the BIOSCIENCE trial.
Franzone A, Heg D, Räber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blöchlinger S, Hunziker L, Praz F, Jüni P, Windecker S, Pilgrim T. Franzone A, et al. Among authors: heg d. Clin Res Cardiol. 2016 Sep;105(9):744-54. doi: 10.1007/s00392-016-0983-z. Epub 2016 Apr 1. Clin Res Cardiol. 2016. PMID: 27033859 Free article. Clinical Trial.
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC, Räber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blöchlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Jüni P, Heg D, Windecker S. Koskinas KC, et al. Among authors: heg d. JACC Cardiovasc Interv. 2016 Jul 25;9(14):1473-83. doi: 10.1016/j.jcin.2016.04.027. JACC Cardiovasc Interv. 2016. PMID: 27478115 Free article.
Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.
Harada Y, Koskinas KC, Ndrepepa G, Räber L, Braun S, Zanchin T, Kufner S, Hunziker L, Byrne RA, Heg D, Kastrati A, Windecker S. Harada Y, et al. Among authors: heg d. Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):480-486. doi: 10.1016/j.carrev.2017.11.010. Epub 2017 Nov 22. Cardiovasc Revasc Med. 2018. PMID: 29292015
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
Zanchin T, Temperli F, Karagiannis A, Zanchin C, Räsänen M, Koskinas KC, Stortecky S, Hunziker L, Praz F, Blöchlinger S, Moro C, Moschovitis A, Seiler C, Billinger M, Heg D, Pilgrim T, Valgimigli M, Windecker S, Räber L. Zanchin T, et al. Among authors: heg d. Circ Cardiovasc Interv. 2018 May;11(5):e006132. doi: 10.1161/CIRCINTERVENTIONS.117.006132. Circ Cardiovasc Interv. 2018. PMID: 29748219
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Muller O, Moarof I, Siontis GCM, Cook S, Weilenmann D, Kaiser C, Cuculi F, Hunziker L, Eberli FR, Jüni P, Windecker S. Pilgrim T, et al. Among authors: heg d. Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28. Lancet. 2018. PMID: 30170848 Clinical Trial.
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
Yamaji K, Zanchin T, Zanchin C, Stortecky S, Koskinas KC, Hunziker L, Praz F, Blöchlinger S, Moro C, Moschovitis A, Seiler C, Valgimigli M, Billinger M, Pilgrim T, Heg D, Windecker S, Räber L. Yamaji K, et al. Among authors: heg d. Circ Cardiovasc Interv. 2018 Sep;11(9):e006741. doi: 10.1161/CIRCINTERVENTIONS.118.006741. Circ Cardiovasc Interv. 2018. PMID: 30354590
Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
Koskinas KC, Ndrepepa G, Räber L, Karagiannis A, Kufner S, Zanchin T, Hieber J, Hunziker L, Mayer K, Byrne RA, Heg D, Windecker S, Kastrati A. Koskinas KC, et al. Among authors: heg d. Circ Cardiovasc Interv. 2018 Dec;11(12):e006752. doi: 10.1161/CIRCINTERVENTIONS.118.006752. Circ Cardiovasc Interv. 2018. PMID: 30545257 Free article.
The hospital results and 1-year outcomes of transcatheter aortic valve-in-valve procedures and transcatheter aortic valve implantations in the native valves: the results from the Swiss-TAVI Registry.
Ferrari E, Stortecky S, Heg D, Muller O, Nietlispach F, Tueller D, Toggweiler S, Noble S, Maisano F, Roffi M, Jeger R, Grünenfelder J, Huber C, Windecker S, Wenaweser P. Ferrari E, et al. Among authors: heg d. Eur J Cardiothorac Surg. 2019 Jul 1;56(1):55-63. doi: 10.1093/ejcts/ezy471. Eur J Cardiothorac Surg. 2019. PMID: 30689870 Free article.
277 results